

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cell wall macromolecule catabolic process (GO:0016998) | 3.59346446 |
| 2 | diacylglycerol metabolic process (GO:0046339) | 3.39993212 |
| 3 | sulfation (GO:0051923) | 3.28774961 |
| 4 | fucose catabolic process (GO:0019317) | 3.25170482 |
| 5 | L-fucose metabolic process (GO:0042354) | 3.25170482 |
| 6 | L-fucose catabolic process (GO:0042355) | 3.25170482 |
| 7 | female mating behavior (GO:0060180) | 3.14177143 |
| 8 | alkaloid metabolic process (GO:0009820) | 3.05653979 |
| 9 | negative regulation of macrophage differentiation (GO:0045650) | 3.04475916 |
| 10 | regulation of guanylate cyclase activity (GO:0031282) | 3.04047874 |
| 11 | cell wall macromolecule metabolic process (GO:0044036) | 2.99875821 |
| 12 | DNA deamination (GO:0045006) | 2.99141024 |
| 13 | response to interferon-beta (GO:0035456) | 2.98731983 |
| 14 | regulation of autophagic vacuole assembly (GO:2000785) | 2.97768253 |
| 15 | mast cell activation involved in immune response (GO:0002279) | 2.94600016 |
| 16 | mast cell degranulation (GO:0043303) | 2.94600016 |
| 17 | positive regulation of antigen processing and presentation (GO:0002579) | 2.84514146 |
| 18 | negative regulation of granulocyte differentiation (GO:0030853) | 2.79190138 |
| 19 | respiratory chain complex IV assembly (GO:0008535) | 2.78780957 |
| 20 | tryptophan catabolic process (GO:0006569) | 2.78599464 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 2.78599464 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 2.78599464 |
| 23 | protein complex biogenesis (GO:0070271) | 2.78410461 |
| 24 | GDP-mannose metabolic process (GO:0019673) | 2.76894916 |
| 25 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.76573643 |
| 26 | cytochrome complex assembly (GO:0017004) | 2.76005390 |
| 27 | regulation of triglyceride catabolic process (GO:0010896) | 2.75937337 |
| 28 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.75641026 |
| 29 | NADH dehydrogenase complex assembly (GO:0010257) | 2.75641026 |
| 30 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.75641026 |
| 31 | mast cell activation (GO:0045576) | 2.74176570 |
| 32 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.72885406 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.69105776 |
| 34 | quinone biosynthetic process (GO:1901663) | 2.68625608 |
| 35 | multicellular organism reproduction (GO:0032504) | 2.67932040 |
| 36 | glutathione biosynthetic process (GO:0006750) | 2.66387428 |
| 37 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.65568638 |
| 38 | indolalkylamine metabolic process (GO:0006586) | 2.64895315 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.64827591 |
| 40 | regulation of granulocyte differentiation (GO:0030852) | 2.64612840 |
| 41 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.64041285 |
| 42 | regulation of female receptivity (GO:0045924) | 2.63542039 |
| 43 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.62453164 |
| 44 | negative regulation of cell killing (GO:0031342) | 2.62453164 |
| 45 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.61151272 |
| 46 | fucosylation (GO:0036065) | 2.59483050 |
| 47 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.56354551 |
| 48 | behavioral response to nicotine (GO:0035095) | 2.56345850 |
| 49 | coenzyme catabolic process (GO:0009109) | 2.56242682 |
| 50 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.55767827 |
| 51 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.54623195 |
| 52 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.54623195 |
| 53 | regulation of cellular extravasation (GO:0002691) | 2.53242631 |
| 54 | negative regulation of telomere maintenance (GO:0032205) | 2.52893921 |
| 55 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.52074725 |
| 56 | immunoglobulin mediated immune response (GO:0016064) | 2.51597385 |
| 57 | regulation of respiratory burst (GO:0060263) | 2.49934854 |
| 58 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.49555596 |
| 59 | regulation of ARF GTPase activity (GO:0032312) | 2.48564687 |
| 60 | cellular response to interferon-beta (GO:0035458) | 2.48474795 |
| 61 | cellular response to exogenous dsRNA (GO:0071360) | 2.47759334 |
| 62 | ATP synthesis coupled proton transport (GO:0015986) | 2.47150327 |
| 63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.47150327 |
| 64 | amine catabolic process (GO:0009310) | 2.44811493 |
| 65 | cellular biogenic amine catabolic process (GO:0042402) | 2.44811493 |
| 66 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.44611717 |
| 67 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.43804859 |
| 68 | regulation of vacuole organization (GO:0044088) | 2.43794677 |
| 69 | deoxyribonucleotide catabolic process (GO:0009264) | 2.43363033 |
| 70 | positive regulation of respiratory burst (GO:0060267) | 2.43156454 |
| 71 | rRNA methylation (GO:0031167) | 2.41292424 |
| 72 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.40398912 |
| 73 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.39346455 |
| 74 | rRNA modification (GO:0000154) | 2.38178588 |
| 75 | regulation of antigen processing and presentation (GO:0002577) | 2.37214291 |
| 76 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.35512157 |
| 77 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.35512157 |
| 78 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.35512157 |
| 79 | modulation by symbiont of host immune response (GO:0052553) | 2.35512157 |
| 80 | positive regulation by symbiont of host defense response (GO:0052509) | 2.35512157 |
| 81 | modulation by symbiont of host defense response (GO:0052031) | 2.35512157 |
| 82 | cofactor catabolic process (GO:0051187) | 2.35452892 |
| 83 | positive regulation of B cell differentiation (GO:0045579) | 2.35419781 |
| 84 | NAD biosynthetic process (GO:0009435) | 2.32273783 |
| 85 | arginine metabolic process (GO:0006525) | 2.30447642 |
| 86 | mannose metabolic process (GO:0006013) | 2.30059762 |
| 87 | base-excision repair, AP site formation (GO:0006285) | 2.29639594 |
| 88 | response to acidic pH (GO:0010447) | 2.29456441 |
| 89 | sulfate transmembrane transport (GO:1902358) | 2.29233522 |
| 90 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.29178733 |
| 91 | positive regulation of granulocyte differentiation (GO:0030854) | 2.28663897 |
| 92 | positive regulation of protein homooligomerization (GO:0032464) | 2.28091280 |
| 93 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.27520265 |
| 94 | high-density lipoprotein particle remodeling (GO:0034375) | 2.27373867 |
| 95 | cytidine deamination (GO:0009972) | 2.27356437 |
| 96 | cytidine metabolic process (GO:0046087) | 2.27356437 |
| 97 | cytidine catabolic process (GO:0006216) | 2.27356437 |
| 98 | deoxyribose phosphate catabolic process (GO:0046386) | 2.25946585 |
| 99 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.24960367 |
| 100 | tryptophan metabolic process (GO:0006568) | 2.24822993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.52270746 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.07620956 |
| 3 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 3.42907984 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.67079887 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.51328005 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.49586152 |
| 7 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.24434123 |
| 8 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.24206444 |
| 9 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 2.04010381 |
| 10 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.96560914 |
| 11 | ERA_21632823_ChIP-Seq_H3396_Human | 1.96196406 |
| 12 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.94201896 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 1.92519931 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88094069 |
| 15 | P68_20966046_ChIP-Seq_HELA_Human | 1.82871076 |
| 16 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.82019258 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80530612 |
| 18 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.76415513 |
| 19 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.75001812 |
| 20 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.74542361 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.71454069 |
| 22 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.68903987 |
| 23 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.66102244 |
| 24 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.65257164 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.63937149 |
| 26 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.62702821 |
| 27 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62146540 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61733636 |
| 29 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.61683641 |
| 30 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.61559576 |
| 31 | P300_27268052_Chip-Seq_Bcells_Human | 1.60794662 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.59395474 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59053870 |
| 34 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.58514503 |
| 35 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.58236465 |
| 36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.57993847 |
| 37 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54238597 |
| 38 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53142613 |
| 39 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.53055410 |
| 40 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.48911326 |
| 41 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.48742789 |
| 42 | SA1_27219007_Chip-Seq_Bcells_Human | 1.47932598 |
| 43 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46667334 |
| 44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.44494638 |
| 45 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.44255793 |
| 46 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.41776227 |
| 47 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.39479789 |
| 48 | * MAF_26560356_Chip-Seq_TH2_Human | 1.37671352 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35181164 |
| 50 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34953944 |
| 51 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.28814519 |
| 52 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.27033659 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.26651824 |
| 54 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.26592237 |
| 55 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.25523858 |
| 56 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.24960460 |
| 57 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.23649104 |
| 58 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.23245696 |
| 59 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.21400764 |
| 60 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.20992393 |
| 61 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.20643875 |
| 62 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20220940 |
| 63 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.19975252 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 1.19524313 |
| 65 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19340169 |
| 66 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18078682 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17699405 |
| 68 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.17570322 |
| 69 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.17398184 |
| 70 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17154868 |
| 71 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.15525415 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15089429 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14934359 |
| 74 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.14750893 |
| 75 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.12800816 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12558424 |
| 77 | NCOR_22424771_ChIP-Seq_293T_Human | 1.11574294 |
| 78 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.09748079 |
| 79 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.08749620 |
| 80 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08532613 |
| 81 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07976019 |
| 82 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 1.07727391 |
| 83 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.07036341 |
| 84 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.06881965 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.06852022 |
| 86 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06491609 |
| 87 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06427988 |
| 88 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.06245781 |
| 89 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.05548034 |
| 90 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05076419 |
| 91 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04341613 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03622642 |
| 93 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02006339 |
| 94 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.01532613 |
| 95 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.01450898 |
| 96 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.01231126 |
| 97 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.00703142 |
| 98 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99787704 |
| 99 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99547151 |
| 100 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.97268435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.73018090 |
| 2 | MP0005360_urolithiasis | 3.37439300 |
| 3 | MP0002132_abnormal_respiratory_system | 2.54277912 |
| 4 | MP0003136_yellow_coat_color | 2.47921618 |
| 5 | MP0003724_increased_susceptibility_to | 2.13345760 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.10898060 |
| 7 | MP0001835_abnormal_antigen_presentation | 1.96484619 |
| 8 | MP0003436_decreased_susceptibility_to | 1.94782132 |
| 9 | MP0005671_abnormal_response_to | 1.92779530 |
| 10 | MP0001986_abnormal_taste_sensitivity | 1.89486343 |
| 11 | MP0003787_abnormal_imprinting | 1.83607644 |
| 12 | MP0004381_abnormal_hair_follicle | 1.81934887 |
| 13 | MP0003878_abnormal_ear_physiology | 1.79877361 |
| 14 | MP0005377_hearing/vestibular/ear_phenot | 1.79877361 |
| 15 | MP0001800_abnormal_humoral_immune | 1.77058033 |
| 16 | MP0003172_abnormal_lysosome_physiology | 1.70956947 |
| 17 | MP0005410_abnormal_fertilization | 1.69274319 |
| 18 | MP0005365_abnormal_bile_salt | 1.68086257 |
| 19 | MP0008872_abnormal_physiological_respon | 1.65718858 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.65271818 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 1.62273034 |
| 22 | MP0000015_abnormal_ear_pigmentation | 1.60364960 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 1.58997800 |
| 24 | MP0005084_abnormal_gallbladder_morpholo | 1.55687733 |
| 25 | MP0002876_abnormal_thyroid_physiology | 1.52984038 |
| 26 | MP0005025_abnormal_response_to | 1.52481647 |
| 27 | MP0005387_immune_system_phenotype | 1.52299927 |
| 28 | MP0001790_abnormal_immune_system | 1.52299927 |
| 29 | MP0003866_abnormal_defecation | 1.49778256 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.49444892 |
| 31 | MP0001485_abnormal_pinna_reflex | 1.48881761 |
| 32 | MP0005174_abnormal_tail_pigmentation | 1.48733455 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.47544372 |
| 34 | MP0000685_abnormal_immune_system | 1.47050839 |
| 35 | MP0009764_decreased_sensitivity_to | 1.46592990 |
| 36 | MP0009785_altered_susceptibility_to | 1.46584264 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.46568649 |
| 38 | MP0003879_abnormal_hair_cell | 1.46129696 |
| 39 | MP0009840_abnormal_foam_cell | 1.45972383 |
| 40 | MP0001666_abnormal_nutrient_absorption | 1.45874138 |
| 41 | MP0002723_abnormal_immune_serum | 1.45107196 |
| 42 | MP0005551_abnormal_eye_electrophysiolog | 1.43292023 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.38882282 |
| 44 | MP0005075_abnormal_melanosome_morpholog | 1.38138631 |
| 45 | MP0002420_abnormal_adaptive_immunity | 1.37609644 |
| 46 | MP0001819_abnormal_immune_cell | 1.37493969 |
| 47 | MP0002419_abnormal_innate_immunity | 1.37206086 |
| 48 | MP0001873_stomach_inflammation | 1.36230671 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.35812344 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.34278929 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 1.32443417 |
| 52 | MP0005058_abnormal_lysosome_morphology | 1.31649115 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.28884640 |
| 54 | MP0010329_abnormal_lipoprotein_level | 1.28582267 |
| 55 | MP0001764_abnormal_homeostasis | 1.26195324 |
| 56 | MP0003195_calcinosis | 1.25297988 |
| 57 | MP0000372_irregular_coat_pigmentation | 1.23689889 |
| 58 | MP0002277_abnormal_respiratory_mucosa | 1.15457130 |
| 59 | MP0008877_abnormal_DNA_methylation | 1.14029092 |
| 60 | MP0004147_increased_porphyrin_level | 1.10774476 |
| 61 | MP0005646_abnormal_pituitary_gland | 1.09392812 |
| 62 | MP0001968_abnormal_touch/_nociception | 1.05792662 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.05174831 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.02920341 |
| 65 | MP0002822_catalepsy | 1.02322251 |
| 66 | MP0006082_CNS_inflammation | 1.01277527 |
| 67 | MP0004133_heterotaxia | 0.98208886 |
| 68 | MP0000716_abnormal_immune_system | 0.97123852 |
| 69 | MP0004043_abnormal_pH_regulation | 0.96970875 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 0.95703896 |
| 71 | MP0003763_abnormal_thymus_physiology | 0.95630561 |
| 72 | MP0005636_abnormal_mineral_homeostasis | 0.95201780 |
| 73 | MP0001663_abnormal_digestive_system | 0.93535047 |
| 74 | MP0005083_abnormal_biliary_tract | 0.93469981 |
| 75 | MP0001664_abnormal_digestion | 0.93374341 |
| 76 | MP0004742_abnormal_vestibular_system | 0.92952638 |
| 77 | MP0008469_abnormal_protein_level | 0.92105007 |
| 78 | MP0003252_abnormal_bile_duct | 0.91772563 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.90729014 |
| 80 | MP0002653_abnormal_ependyma_morphology | 0.89339219 |
| 81 | MP0002160_abnormal_reproductive_system | 0.89332878 |
| 82 | MP0001756_abnormal_urination | 0.86328770 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.85633116 |
| 84 | MP0001533_abnormal_skeleton_physiology | 0.84366996 |
| 85 | MP0002398_abnormal_bone_marrow | 0.83885947 |
| 86 | MP0001765_abnormal_ion_homeostasis | 0.83654153 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.83215276 |
| 88 | MP0002272_abnormal_nervous_system | 0.83155228 |
| 89 | MP0006292_abnormal_olfactory_placode | 0.82436832 |
| 90 | MP0006276_abnormal_autonomic_nervous | 0.81971061 |
| 91 | MP0005319_abnormal_enzyme/_coenzyme | 0.81812573 |
| 92 | MP0001905_abnormal_dopamine_level | 0.81229593 |
| 93 | MP0005332_abnormal_amino_acid | 0.81229550 |
| 94 | MP0000465_gastrointestinal_hemorrhage | 0.81182518 |
| 95 | MP0008004_abnormal_stomach_pH | 0.81113864 |
| 96 | MP0001486_abnormal_startle_reflex | 0.80735914 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.80015906 |
| 98 | MP0002405_respiratory_system_inflammati | 0.79571465 |
| 99 | MP0008260_abnormal_autophagy | 0.74904093 |
| 100 | MP0002429_abnormal_blood_cell | 0.74138058 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.47274539 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.32151372 |
| 3 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.30834702 |
| 4 | Bile duct proliferation (HP:0001408) | 3.05503186 |
| 5 | Abnormal biliary tract physiology (HP:0012439) | 3.05503186 |
| 6 | Congenital stationary night blindness (HP:0007642) | 3.05132506 |
| 7 | Abnormality of midbrain morphology (HP:0002418) | 2.97672456 |
| 8 | Molar tooth sign on MRI (HP:0002419) | 2.97672456 |
| 9 | Hepatocellular necrosis (HP:0001404) | 2.90371379 |
| 10 | Myositis (HP:0100614) | 2.75728256 |
| 11 | Pancreatic cysts (HP:0001737) | 2.73104415 |
| 12 | Mitochondrial inheritance (HP:0001427) | 2.73060674 |
| 13 | Panhypogammaglobulinemia (HP:0003139) | 2.68530819 |
| 14 | Severe visual impairment (HP:0001141) | 2.64004797 |
| 15 | Stomatitis (HP:0010280) | 2.58253851 |
| 16 | Increased CSF lactate (HP:0002490) | 2.47913307 |
| 17 | Hepatic necrosis (HP:0002605) | 2.47286022 |
| 18 | Pustule (HP:0200039) | 2.42411453 |
| 19 | Nephronophthisis (HP:0000090) | 2.39010453 |
| 20 | Clumsiness (HP:0002312) | 2.37354468 |
| 21 | Attenuation of retinal blood vessels (HP:0007843) | 2.35795520 |
| 22 | Pancreatic fibrosis (HP:0100732) | 2.35011346 |
| 23 | True hermaphroditism (HP:0010459) | 2.34667262 |
| 24 | Chronic hepatic failure (HP:0100626) | 2.32415368 |
| 25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.30856417 |
| 26 | Type II lissencephaly (HP:0007260) | 2.30467790 |
| 27 | Acute necrotizing encephalopathy (HP:0006965) | 2.24299180 |
| 28 | Petechiae (HP:0000967) | 2.23647880 |
| 29 | Cystic liver disease (HP:0006706) | 2.17924755 |
| 30 | Acute encephalopathy (HP:0006846) | 2.15488975 |
| 31 | Abnormality of DNA repair (HP:0003254) | 2.13581472 |
| 32 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.12654679 |
| 33 | Congenital sensorineural hearing impairment (HP:0008527) | 2.12527747 |
| 34 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.12452433 |
| 35 | Hypochromic anemia (HP:0001931) | 2.11129390 |
| 36 | Recurrent fungal infections (HP:0002841) | 2.10434483 |
| 37 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.09331681 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07690879 |
| 39 | Obstructive lung disease (HP:0006536) | 2.07493971 |
| 40 | Chronic obstructive pulmonary disease (HP:0006510) | 2.07493971 |
| 41 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.06001951 |
| 42 | Orchitis (HP:0100796) | 2.05477098 |
| 43 | Recurrent abscess formation (HP:0002722) | 2.05377728 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.05354857 |
| 45 | Abolished electroretinogram (ERG) (HP:0000550) | 2.05108784 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.04797373 |
| 47 | Asplenia (HP:0001746) | 2.04678164 |
| 48 | Ketosis (HP:0001946) | 2.04403539 |
| 49 | Optic neuritis (HP:0100653) | 2.04086565 |
| 50 | Retrobulbar optic neuritis (HP:0100654) | 2.04086565 |
| 51 | Decreased central vision (HP:0007663) | 2.01797697 |
| 52 | Abnormality of the renal medulla (HP:0100957) | 2.00716422 |
| 53 | Prolonged bleeding time (HP:0003010) | 1.99823950 |
| 54 | Pigmentary retinal degeneration (HP:0001146) | 1.99694618 |
| 55 | Encephalitis (HP:0002383) | 1.99354068 |
| 56 | Abnormality of dental color (HP:0011073) | 1.98770536 |
| 57 | Optic disc pallor (HP:0000543) | 1.96974075 |
| 58 | Abnormal number of erythroid precursors (HP:0012131) | 1.96691240 |
| 59 | Granulocytopenia (HP:0001913) | 1.94515261 |
| 60 | Absent thumb (HP:0009777) | 1.91319345 |
| 61 | Hyperglycinuria (HP:0003108) | 1.90779522 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 1.90660506 |
| 63 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.90218350 |
| 64 | Abnormality of urine glucose concentration (HP:0011016) | 1.89288847 |
| 65 | Glycosuria (HP:0003076) | 1.89288847 |
| 66 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.89026652 |
| 67 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.89026652 |
| 68 | Eosinophilia (HP:0001880) | 1.88511112 |
| 69 | Keratoconjunctivitis (HP:0001096) | 1.87754655 |
| 70 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87187318 |
| 71 | Dicarboxylic aciduria (HP:0003215) | 1.87187318 |
| 72 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.85706754 |
| 73 | Recurrent cutaneous fungal infections (HP:0011370) | 1.85706754 |
| 74 | Methylmalonic aciduria (HP:0012120) | 1.85501228 |
| 75 | Lipid accumulation in hepatocytes (HP:0006561) | 1.85329128 |
| 76 | Cerebral palsy (HP:0100021) | 1.85281702 |
| 77 | Concave nail (HP:0001598) | 1.84808936 |
| 78 | Malnutrition (HP:0004395) | 1.84394143 |
| 79 | Increased serum ferritin (HP:0003281) | 1.84287890 |
| 80 | IgG deficiency (HP:0004315) | 1.78164974 |
| 81 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77913853 |
| 82 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.76674268 |
| 83 | Absent/shortened dynein arms (HP:0200106) | 1.74840574 |
| 84 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.74840574 |
| 85 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.73456459 |
| 86 | Hyperglycinemia (HP:0002154) | 1.73372648 |
| 87 | Increased muscle lipid content (HP:0009058) | 1.73126027 |
| 88 | Lactic acidosis (HP:0003128) | 1.73114827 |
| 89 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.73090941 |
| 90 | Abnormality of glycine metabolism (HP:0010895) | 1.73090941 |
| 91 | Tetany (HP:0001281) | 1.72034702 |
| 92 | Vasculitis (HP:0002633) | 1.70714803 |
| 93 | Progressive macrocephaly (HP:0004481) | 1.70233775 |
| 94 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.70017894 |
| 95 | Rib fusion (HP:0000902) | 1.69553762 |
| 96 | Abnormality of iron homeostasis (HP:0011031) | 1.68647913 |
| 97 | Leukocytosis (HP:0001974) | 1.65903951 |
| 98 | Male pseudohermaphroditism (HP:0000037) | 1.65399484 |
| 99 | Increased serum lactate (HP:0002151) | 1.65104969 |
| 100 | Lethargy (HP:0001254) | 1.64621104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 3.96134025 |
| 2 | TLK1 | 3.20705929 |
| 3 | MAP4K1 | 2.75745995 |
| 4 | TXK | 2.65121725 |
| 5 | WNK4 | 2.54987905 |
| 6 | TNK2 | 2.45925210 |
| 7 | SIK2 | 2.37210190 |
| 8 | GRK6 | 2.35258247 |
| 9 | NME1 | 2.18095159 |
| 10 | FRK | 2.17116607 |
| 11 | MAP4K2 | 2.16333938 |
| 12 | MARK3 | 2.13475195 |
| 13 | RIPK4 | 1.93211435 |
| 14 | INSRR | 1.88183224 |
| 15 | NME2 | 1.83511124 |
| 16 | ADRBK2 | 1.71939085 |
| 17 | GRK1 | 1.70660277 |
| 18 | MAP2K6 | 1.70558618 |
| 19 | SYK | 1.65217510 |
| 20 | BTK | 1.61096614 |
| 21 | BLK | 1.60842951 |
| 22 | FES | 1.58268959 |
| 23 | TYK2 | 1.57157545 |
| 24 | BMPR1B | 1.56865356 |
| 25 | TAOK3 | 1.55620878 |
| 26 | ACVR1B | 1.50184228 |
| 27 | ERN1 | 1.41925046 |
| 28 | ZAK | 1.38675188 |
| 29 | MAPK15 | 1.38561763 |
| 30 | OXSR1 | 1.25045593 |
| 31 | TNIK | 1.22031263 |
| 32 | PRKCQ | 1.21273727 |
| 33 | KIT | 1.19309550 |
| 34 | ZAP70 | 1.18487533 |
| 35 | TEC | 1.16337542 |
| 36 | BCKDK | 1.11515866 |
| 37 | ITK | 1.11420020 |
| 38 | IKBKB | 1.05807363 |
| 39 | LYN | 1.02224013 |
| 40 | MAP3K11 | 0.96057163 |
| 41 | MAP2K2 | 0.95626220 |
| 42 | NUAK1 | 0.94637673 |
| 43 | IRAK4 | 0.90873971 |
| 44 | IKBKE | 0.90804503 |
| 45 | MUSK | 0.90684921 |
| 46 | PRKG2 | 0.90470637 |
| 47 | DYRK2 | 0.89678777 |
| 48 | CDK19 | 0.87843928 |
| 49 | MAPKAPK3 | 0.86398852 |
| 50 | MAP2K3 | 0.86070431 |
| 51 | MAPK13 | 0.85613719 |
| 52 | PDK2 | 0.85059908 |
| 53 | TBK1 | 0.82773028 |
| 54 | STK39 | 0.80932093 |
| 55 | DAPK2 | 0.80745981 |
| 56 | NEK2 | 0.79169866 |
| 57 | CSF1R | 0.78014992 |
| 58 | MAP2K7 | 0.77040782 |
| 59 | LCK | 0.73541428 |
| 60 | HCK | 0.72843037 |
| 61 | MAP3K1 | 0.70374283 |
| 62 | MST1R | 0.68093142 |
| 63 | MATK | 0.67739618 |
| 64 | CSK | 0.66356219 |
| 65 | VRK2 | 0.66353205 |
| 66 | WNK3 | 0.64780378 |
| 67 | PDK1 | 0.64487051 |
| 68 | PDPK1 | 0.60095455 |
| 69 | MAPK12 | 0.59293347 |
| 70 | ADRBK1 | 0.57621883 |
| 71 | PRKCI | 0.55394306 |
| 72 | RPS6KA6 | 0.54578075 |
| 73 | PTK2B | 0.54255153 |
| 74 | CSNK1G3 | 0.54151892 |
| 75 | GRK5 | 0.52611086 |
| 76 | FGR | 0.51167404 |
| 77 | DAPK1 | 0.49378957 |
| 78 | STK38 | 0.49201105 |
| 79 | JAK3 | 0.46640887 |
| 80 | PRKCZ | 0.45752298 |
| 81 | NTRK3 | 0.45248832 |
| 82 | TAOK1 | 0.45164852 |
| 83 | PIM2 | 0.43098667 |
| 84 | MAPK11 | 0.43018523 |
| 85 | GRK7 | 0.42759983 |
| 86 | RPS6KA2 | 0.42567972 |
| 87 | FGFR2 | 0.41448217 |
| 88 | RPS6KA5 | 0.41017214 |
| 89 | RPS6KL1 | 0.40951685 |
| 90 | RPS6KC1 | 0.40951685 |
| 91 | PAK3 | 0.40763326 |
| 92 | NTRK2 | 0.40248110 |
| 93 | CDK3 | 0.38127460 |
| 94 | PRKCG | 0.37600064 |
| 95 | KDR | 0.36298644 |
| 96 | MAP3K3 | 0.35837703 |
| 97 | CDC42BPA | 0.35764581 |
| 98 | SIK1 | 0.35717344 |
| 99 | PRKCD | 0.35070876 |
| 100 | ABL2 | 0.35053048 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.81913821 |
| 2 | Asthma_Homo sapiens_hsa05310 | 2.73028414 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.38904435 |
| 4 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.24737696 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.23695214 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23220358 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.20980579 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 2.19064762 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.15379228 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.12497152 |
| 11 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.02956103 |
| 12 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.98777821 |
| 13 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.98629149 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.85052233 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.80355573 |
| 16 | Phototransduction_Homo sapiens_hsa04744 | 1.78355133 |
| 17 | Parkinsons disease_Homo sapiens_hsa05012 | 1.73085978 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.71738866 |
| 19 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.68181519 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.62609030 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.62110323 |
| 22 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.58223799 |
| 23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.51843141 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.49354129 |
| 25 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.46608631 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.45515583 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.38866290 |
| 28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.36441720 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35512538 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.34208022 |
| 31 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.33106045 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.31141545 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.30129633 |
| 34 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.25119810 |
| 35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21687539 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.21669750 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.16009287 |
| 38 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.14295390 |
| 39 | RNA polymerase_Homo sapiens_hsa03020 | 1.13407056 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.13015026 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.11797794 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11328737 |
| 43 | Peroxisome_Homo sapiens_hsa04146 | 1.10386904 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09492752 |
| 45 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.08038586 |
| 46 | Ribosome_Homo sapiens_hsa03010 | 1.06748266 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.06613066 |
| 48 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.03926376 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.01630524 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01343129 |
| 51 | Mineral absorption_Homo sapiens_hsa04978 | 0.96512737 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.96117049 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.96063617 |
| 54 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93413422 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 0.92884772 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.92815633 |
| 57 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91123272 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90629713 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89770137 |
| 60 | Huntingtons disease_Homo sapiens_hsa05016 | 0.84275814 |
| 61 | Histidine metabolism_Homo sapiens_hsa00340 | 0.81880439 |
| 62 | Homologous recombination_Homo sapiens_hsa03440 | 0.81177884 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79509526 |
| 64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78980228 |
| 65 | Proteasome_Homo sapiens_hsa03050 | 0.77078123 |
| 66 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.74788166 |
| 67 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71199368 |
| 68 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.70988578 |
| 69 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.70578985 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.69866735 |
| 71 | Tuberculosis_Homo sapiens_hsa05152 | 0.68118080 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66244642 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63478176 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63285596 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62481240 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.62201989 |
| 77 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59331484 |
| 78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.58433459 |
| 79 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.58108037 |
| 80 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57327837 |
| 81 | Salivary secretion_Homo sapiens_hsa04970 | 0.57260213 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57044709 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56545160 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55190214 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51793823 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51695647 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50754565 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50068246 |
| 89 | Taste transduction_Homo sapiens_hsa04742 | 0.45733475 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.43133828 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42579134 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.42142694 |
| 93 | Pertussis_Homo sapiens_hsa05133 | 0.41791455 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40022445 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.39858176 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38898243 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38323658 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.36614242 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.36423046 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.36080737 |

